These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7828694)

  • 41. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
    Darken P; DePetrillo P; Reisner C; St Rose E; Dorinsky P
    Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
    Silkstone VL; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
    Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
    Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer.
    Goldberg S; Einot T; Algur N; Schwartz S; Greenberg AC; Picard E; Virgilis D; Kerem E
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):566-71. PubMed ID: 12487221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
    Derom E; Borgström L; Van Schoor J; Löfroos AB; Pauwels R
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1398-402. PubMed ID: 11704585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical pharmacokinetics of inhaled budesonide.
    Donnelly R; Seale JP
    Clin Pharmacokinet; 2001; 40(6):427-40. PubMed ID: 11475468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
    Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
    Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novolizer: a multidose dry powder inhaler.
    Fenton C; Keating GM; Plosker GL
    Drugs; 2003; 63(22):2437-45; discussion 2447-8. PubMed ID: 14609355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler.
    Borgström L; Asking L; Thorsson L
    Int J Clin Pract; 2005 Dec; 59(12):1488-95. PubMed ID: 16351685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New method of evaluating patient preference for different inhalation delivery systems.
    Boe J; Stiksa G; Svensson K; Asbrink E
    Ann Allergy; 1992 Mar; 68(3):255-60. PubMed ID: 1546821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients.
    Selroos O; Backman R; Forsén KO; Löfroos AB; Niemistö M; Pietinalho A; Riska H
    Allergy; 1994 Dec; 49(10):833-6. PubMed ID: 7709992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol.
    Grekas N; Athanassiou K; Papataxiarchou K; Rizea Savu S; Silvestro L
    J Pharm Pharmacol; 2014 Dec; 66(12):1677-85. PubMed ID: 25109416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of budesonide Turbuhaler in young children suspected of asthma.
    Bisgaard H; Pedersen S; Nikander K
    Eur Respir J; 1994 Apr; 7(4):740-2. PubMed ID: 8005258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma.
    Ige OM; Sogaolu OM
    Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma.
    Davis KC; Small RE
    Pharmacotherapy; 1998; 18(4):720-8. PubMed ID: 9692646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nasal distribution of budesonide inhaled via a powder inhaler.
    Thorsson L; Newman SP; Weisz A; Trofast E; Morén F
    Rhinology; 1993 Mar; 31(1):7-10. PubMed ID: 8321983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro, ex vivo, in vivo veritas.
    Borgström L
    Allergy; 1999; 54 Suppl 49():88-92. PubMed ID: 10422754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.